Literature DB >> 7528245

Differential responsiveness of Langerhans cell subsets of varying phenotypic states in normal human epidermis.

A Shibaki1, L Meunier, C Ra, S Shimada, A Ohkawara, K D Cooper.   

Abstract

Epidermal Langerhans cell heterogeneity is poorly understood with regard to phenotypic characteristics, such as the expression of human leukocyte antigen (HLA)-DR, integrin, and Fc receptor molecules, as well as functional characteristics, such as the ability to process and present antigens or produce cytokines during various phases of immigration and maturation. Technical limitations of Langerhans cell number have limited functional assays on putative Langerhans cell subsets in in vivo epidermis. Therefore, we used flow cytometry for simultaneous phenotypic and functional assessment at the single-cell level within the Langerhans cell population. Freshly isolated human epidermal cell suspensions were stained with a battery of monoclonal antibodies, including anti-HLA-DR, -CD1a, -CD1c, -CD11c, -Fc gamma RII, and -Fc epsilon RI. Two distinct Langerhans cell subsets were identified by their different levels of HLA-DR expression. The DRHi subset expressed higher amounts of CD11c and exhibited greater cytoplasmic complexity and higher baseline calcium than the DRLo subset (p < or = 0.03 for each). Some subjects also expressed high levels of Fc epsilon RI in the DRHi, CD11cHi subset. To determine whether these phenotypic subsets may exhibit differential signal-transduction functional properties, Langerhans cells were partially enriched over Ficoll-Hypaque and their cytosolic mobilization after the addition of ionomycin was analyzed using the calcium indicator, indo-1, in conjunction with quantitative analysis of HLA-DR expression. By this real-time flow cytometric analysis, a new subpopulation was revealed within the DRLo Langerhans cell subset. This subset increased its cytosolic calcium concentration much more than the other two subsets (change in indo-1 blue:violet emission ratio of 37.33 +/- 2.34 in the Hi Flux DRLo subset versus 13.23 +/- 0.29 in the Lo Flux DRLo subset, and versus 7.6 +/- 2.99 in the Lo Flux DRHi subset). These data indicate that functional, as well as phenotypic, subsets of Langerhans cells exist within normal human epidermis. Their responses to physiologic stimuli may relate to maturational stage or the level of in vivo activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528245     DOI: 10.1111/1523-1747.ep12613476

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells.

Authors:  K Takahashi; K Asagoe; J Zaishun; H Yanai; T Yoshino; K Hayashi; T Akagi
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

2.  Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells.

Authors:  A Morelli; A Larregina; I Chuluyán; E Kolkowski; L Fainboim
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

3.  IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin.

Authors:  M Cumberbatch; M Bhushan; R J Dearman; I Kimber; C E M Griffiths
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

4.  Interoperability of RTN1A in dendrite dynamics and immune functions in human Langerhans cells.

Authors:  Małgorzata Anna Cichoń; Karin Pfisterer; Judith Leitner; Lena Wagner; Clement Staud; Peter Steinberger; Adelheid Elbe-Bürger
Journal:  Elife       Date:  2022-10-12       Impact factor: 8.713

5.  Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells.

Authors:  Claire S Leitch; Eenass Natafji; Cunjing Yu; Sharizan Abdul-Ghaffar; Nayani Madarasingha; Zoë C Venables; Roland Chu; Paul M Fitch; Andrew J Muinonen-Martin; Linda E Campbell; W H Irwin McLean; Jürgen Schwarze; Sarah E M Howie; Richard B Weller
Journal:  J Allergy Clin Immunol       Date:  2016-03-02       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.